1 Patient Report Specimen ID: [REDACTED_PHONE]-0 Acct #: 09018260 Phone: [REDACTED_PHONE] Rte: 00 Control ID: B0075304451 4PMD 4910 E Adamo Dr Unit B TAMPA FL 33605 [REDACTED_NAME] DOB: [REDACTED] Age(y/m/d): 029/03/12 Gender: M SSN: Patient ID: DL 14997 Specimen Details Date collected: 05/12/2018 0950 Local Date received: 05/12/2018 Date entered: 05/12/2018 Date reported: 05/19/2018 0823 ET Physician Details Ordering: R MCCLAIN Referring: ID: 15759893 NPI: [REDACTED_ID]  Date Issued: 05/21/18 1316 ET FINAL REPORT Page 1 of 3 This document contains private and confidential health information protected by state and federal law. If you have received this document in error, please call [REDACTED_PHONE] © 1995-2018 Laboratory Corporation of America ® Holdings All Rights Reserved - Enterprise Report Version: General Comments & Additional Information Alternate Control Number: B0075304451 Alternate [REDACTED_ID] Provided Total Volume: Not Provided Fasting: Yes Ordered Items CBC With Differential/Platelet; Comp. Metabolic Panel (14); Lipid Panel w/ Chol/HDL Ratio; FSH and LH; Testosterone, Free+Total LC/MS; DHEA-Sulfate; TSH; Prostate-Specific Ag, Serum; Estradiol, Sensitive; Triiodothyronine,Free,Serum; Sex Horm Binding Glob, Serum; Venipuncture TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB CBC With Differential/Platelet WBC 5.2 x10E3/uL 3.4 - 10.8 01 RBC 4.97 x10E6/uL 4.14 - 5.80 01 Hemoglobin 15.0 g/dL 13.0 - 17.7 01 Hematocrit 45.6 % 37.5 - 51.0 01 MCV 92 fL 79 - 97 01 MCH 30.2 pg 26.6 - 33.0 01 MCHC 32.9 g/dL 31.5 - 35.7 01 RDW 13.0 % 12.3 - 15.4 01 Platelets 132 Low x10E3/uL 150 - 379 01 Neutrophils 53 % Not Estab. 01 Lymphs 36 % Not Estab. 01 Monocytes 7 % Not Estab. 01 Eos 3 % Not Estab. 01 Basos 1 % Not Estab. 01 Neutrophils (Absolute) 2.7 x10E3/uL 1.4 - 7.0 01 Lymphs (Absolute) 1.9 x10E3/uL 0.7 - 3.1 01 Monocytes(Absolute) 0.4 x10E3/uL 0.1 - 0.9 01 Eos (Absolute) 0.2 x10E3/uL 0.0 - 0.4 01 Baso (Absolute) 0.0 x10E3/uL 0.0 - 0.2 01 Immature Granulocytes 0 % Not Estab. 01 Immature Grans (Abs) 0.0 x10E3/uL 0.0 - 0.1 01 Comp. Metabolic Panel (14) Glucose 88 mg/dL 65 - 99 01 BUN 18 mg/dL 6 - 20 01 Creatinine 1.07 mg/dL 0.76 - 1.27 01 eGFR If NonAfricn Am 93 mL/min/1.73 >59 eGFR If Africn Am 108 mL/min/1.73 >59 1.00
1 Patient Report Specimen ID: [REDACTED_PHONE]-0 Control ID: B0075304451 Date collected: 05/12/2018 0950 Local Date Issued: 05/21/18 1316 ET FINAL REPORT Page 2 of 3 This document contains private and confidential health information protected by state and federal law. If you have received this document in error, please call [REDACTED_PHONE] © 1995-2018 Laboratory Corporation of America ® Holdings All Rights Reserved - Enterprise Report Version: TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB BUN/Creatinine Ratio 17 9 - 20 Sodium 143 mmol/L 134 - 144 01 Potassium 4.1 mmol/L 3.5 - 5.2 01 Chloride 100 mmol/L 96 - 106 01 Carbon Dioxide, Total 23 mmol/L 18 - 29 01 Calcium 9.2 mg/dL 8.7 - 10.2 01 Protein, Total 6.4 g/dL 6.0 - 8.5 01 Albumin 4.8 g/dL 3.5 - 5.5 01 Globulin, Total 1.6 g/dL 1.5 - 4.5 A/G Ratio 3.0 High 1.2 - 2.2 Bilirubin, Total 0.7 mg/dL 0.0 - 1.2 01 Alkaline Phosphatase 58 IU/L 39 - 117 01 AST (SGOT) 21 IU/L 0 - 40 01 ALT (SGPT) 16 IU/L 0 - 44 01 Lipid Panel w/ Chol/HDL Ratio Cholesterol, Total 201 High mg/dL 100 - 199 01 Triglycerides 58 mg/dL 0 - 149 01 HDL Cholesterol 75 mg/dL >39 01 VLDL Cholesterol Cal 12 mg/dL 5 - 40 LDL Cholesterol Calc 114 High mg/dL 0 - 99 T. Chol/HDL Ratio 2.7 ratio 0.0 - 5.0 Please Note: 01 T. Chol/HDL Ratio Men Women 1/2 Avg.Risk 3.4 3.3 Avg.Risk 5.0 4.4 2X Avg.Risk 9.6 7.1 3X Avg.Risk 23.4 11.0 FSH and LH LH 4.1 mIU/mL 1.7 - 8.6 01 FSH 6.5 mIU/mL 1.5 - 12.4 01 Testosterone, Free+Total LC/MS Testosterone, Total, LC/MS 572.7 ng/dL 264.0 - 916.0 02 This LabCorp LC/MS-MS method is currently certified by the CDC Hormone Standardization Program (HoSt). Adult male reference interval is based on a population of healthy nonobese males (BMI <30) between 19 and 39 years old. Travison, et.al. JCEM 2017,102;1161-1173. PMID: 28324103. Disclaimer: 02 This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration. Free Testosterone(Direct) 8.0 Low pg/mL 9.3 - 26.5 02 1.00
1 Patient Report Specimen ID: [REDACTED_PHONE]-0 Control ID: B0075304451 Date collected: 05/12/2018 0950 Local Date Issued: 05/21/18 1316 ET FINAL REPORT Page 3 of 3 This document contains private and confidential health information protected by state and federal law. If you have received this document in error, please call [REDACTED_PHONE] © 1995-2018 Laboratory Corporation of America ® Holdings All Rights Reserved - Enterprise Report Version: TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB DHEA-Sulfate 240.3 ug/dL 138.5 - 475.2 01 TSH 1.190 uIU/mL 0.450 - 4.500 01 Prostate-Specific Ag, Serum Prostate Specific Ag, Serum 0.6 ng/mL 0.0 - 4.0 01 Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory PSA value 0.2 ng/mL or greater. Values obtained with different assay methods or kits cannot be used interchangeably. Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease. Estradiol, Sensitive 24.2 pg/mL 8.0 - 35.0 02 This test was developed and its performance characteristics determined by LabCorp. It has not been cleared by the Food and Drug Administration. Methodology: Liquid chromatography tandem mass spectrometry(LC/MS/MS) Triiodothyronine,Free,Serum 3.3 pg/mL 2.0 - 4.4 01 Sex Horm Binding Glob, Serum 67.3 High nmol/L 16.5 - 55.9 01 01 SE LabCorp Seattle 550 17th Avenue Ste 300, Seattle, WA 98122-5789 Dir: [REDACTED_PROVIDER] 02 BN LabCorp Burlington 1447 York Court, Burlington, NC 27215-3361 Dir: [REDACTED_PROVIDER] For inquiries, the physician may contact Branch: [REDACTED_PHONE] Lab: [REDACTED_PHONE] 1.00
